ImmunityBio, Inc. IBRX
Set alert
8.29 USD -0.45 -5.15%
At close · Oct 30
8.29 0.00 0.00%
After hours · Oct 30, 7:55 PM ET
8.12 Day range 8.72
1.98 52-week range 11.55
- YTD
- +318.69%
- 1 year
- +251.27%
- Open
- 8.48
- Prev close
- 8.74
- Mkt cap
- 8.79B
- Vol
- 8.96M
- Avg vol
- 11.49M
- EPS
- -0.96
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.12
- High
- 8.72
- Forward P/E
- -113.05
- Beta
- 0.03
- Short ratio
- 7.96
- Inst. own
- 19.80%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 8.70
- 200-d avg
- 7.88
- 1y target
- 14.25
MAX chart
Events in this range
- Aug 5, 2025Earnings: -0.1; estimate -0.1; surprise 0%
- Nov 4, 2025Earnings: -0.07; estimate -0.1; surprise 30%
- May 5, 2026Rating: D. Boral Capital · Buy → Buy
- May 7, 2026Earnings: -0.62; estimate -0.08; surprise -675%
- Jun 2, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Aug 4, 2026Earnings: -0.22; estimate -0.08; surprise -175%
- Nov 3, 2026Earnings: —; estimate -0.07; surprise —%
Signals (29)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Feb 1, 2026 | 9 months ago |
| SMA: Bullish | Jan 1, 2026 | 10 months ago |
| SMA: Bullish | Jan 1, 2026 | 10 months ago |
| MACD: Buy Signal | Jan 1, 2026 | 10 months ago |
| MACD: Sell Signal | Jan 1, 2025 | 1 year ago |
| SMA: Bearish | Dec 1, 2024 | 1 year ago |
| SMA: Bullish | Oct 1, 2024 | 2 years ago |
| SMA: Bearish | Aug 1, 2024 | 2 years ago |
| SMA: Bearish | Aug 1, 2024 | 2 years ago |
| SMA: Bullish | Feb 1, 2024 | 2 years ago |
| SMA: Bearish | Jan 1, 2024 | 2 years ago |
| SMA: Bullish | Dec 1, 2023 | 2 years ago |
| SMA: Bullish | Oct 1, 2023 | 3 years ago |
| MACD: Buy Signal | Oct 1, 2023 | 3 years ago |
| SMA: Bearish | Jan 1, 2023 | 3 years ago |
| SMA: Bullish | Sep 1, 2022 | 4 years ago |
| SMA: Bearish | Oct 1, 2021 | 5 years ago |
| MACD: Sell Signal | Aug 1, 2021 | 5 years ago |
| SMA: Bearish | Jun 1, 2021 | 5 years ago |
| RSI: Overbought | Jan 1, 2021 | 5 years ago |
| RSI: Overbought | Jun 1, 2020 | 6 years ago |
| SMA: Bullish | Dec 1, 2019 | 6 years ago |
| SMA: Bullish | Nov 1, 2019 | 7 years ago |
| SMA: Bearish | Oct 1, 2019 | 7 years ago |
| SMA: Bullish | Jul 1, 2019 | 7 years ago |
| RSI: Oversold | Dec 1, 2018 | 7 years ago |
| SMA: Bearish | Oct 1, 2017 | 9 years ago |
| SMA: Bullish | Jun 1, 2017 | 9 years ago |
| RSI: Oversold | Mar 1, 2017 | 9 years ago |
Ownership
Held by insiders 62.15%
Held by institutions 19.80%
Float held by institutions 52.32%
Institutions 507
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 3.22% | 34,083,262 | 282.55M | Jun 29, 2026 |
| State Street Corporation | 2.02% | 21,398,438 | 177.39M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 1.69% | 17,863,911 | 148.09M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 1.48% | 15,691,579 | 130.08M | Jun 29, 2026 |
| Shaw D.E. & Co., Inc. | 1.09% | 11,551,019 | 95.76M | Jun 29, 2026 |
| Two Sigma Investments, LP | 1.05% | 11,097,106 | 92.00M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.10% | 11,702,382 | 97.01M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.09% | 11,597,491 | 96.14M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 0.94% | 9,991,183 | 82.83M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 0.79% | 8,399,273 | 69.63M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 0.46% | 4,852,894 | 40.23M | Jun 29, 2026 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 0.40% | 4,224,658 | 35.02M | Jul 30, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ADCOCK RICHARD | Chief Executive Officer | Conversion of Exercise of derivative security | Feb 19, 2026 | 560,344 |
| COHEN CHERYL L | Director | Sale | Oct 1, 2026 | 100,309 |
| REGAN LAUER | Officer | Conversion of Exercise of derivative security | Feb 19, 2026 | 115,875 |
| SACHS DAVID C | Chief Financial Officer | Conversion of Exercise of derivative security | Feb 19, 2026 | 300,143 |
| SELECKY CHRISTOBEL E. | Director | Sale | Jun 30, 2026 | 0 |
| SIMON BARRY J. M.D. | Director | Sale | Oct 4, 2026 | 2,777,790 |
Held by funds
112 US ETFs and mutual funds hold IBRX · largest positions